Evidence map›Paper›PMID 26600814›Full record

ArticleThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale

Blastomycosis in northwestern Ontario, 2004 to 2014.

Daniel Dalcin, Syed Zaki Ahmed

Open access · goldAbstract read
In one paragraph

Article in The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Human immunity to fungal infections.The Journal of experimental medicine · 2025
    Review
  2. Perspectives on blastomycosis in Canada in the face of climate change.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2024
    Article
  3. Article
  4. Article
  5. Blastomycosis in Minnesota, USA, 1999-2018.Emerging infectious diseases · 2020
    Article
  6. Review
  7. Article
  8. Blastomycosis hospitalizations in northwestern Ontario: 2006-2015.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2017
    Article
  9. Serious fungal infections in Canada.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2017
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Daniel DalcinNorthern Ontario School of Medicine, Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario.
Syed Zaki AhmedNorthern Ontario School of Medicine, Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario ; Department of Internal Medicine, Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario.
NOSM University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blastomycosis is an invasive fungal disease caused by Blastomyces dermatitidis and the recently discovered Blastomyces gilchristii. The medical charts of 64 patients with confirmed cases of blastomycosis in northwestern Ontario during a 10-year period (2004 to 2014) were retrospectively reviewed. The number of patients diagnosed with blastomycosis in Ontario was observed to have increased substantially compared with before 1990, when blastomycosis was removed from the list of reportable diseases. Aboriginals were observed to be disproportionately represented in the patient population. Of the patients whose smoking status was known, 71.4% had a history of smoking. 59.4% of patients had underlying comorbidities and a higher comorbidity rate was observed among Aboriginal patients. The case-fatality rate from direct complications of blastomycosis disease was calculated to be 20.3%; this case-fatality rate is the highest ever to be reported in Canada and more than double that of previously published Canadian studies. The clinical characteristics of 64 patients diagnosed with blastomycosis are summarized.

Indexed as

AboriginalBlastomycosisCase-fatalityClinical characteristicsNorthwestern OntarioSmoking

Identifiers

PMID26600814
PMCPMC4644009
OpenAlexW1898537091

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.